Table I.
Clinicopathological features | Total n (n=100) | miR-3664-5P expression
|
P-value | |
---|---|---|---|---|
Low
|
High
|
|||
No. of patients (%) | No. of patients (%) | |||
Sex | 0.826 | |||
Male | 71 | 36 (72.0) | 35 (70.0) | |
Female | 29 | 14 (28.0) | 15 (30.0) | |
Age, years | 0.406 | |||
≤50 | 64 | 30 (60.0) | 34 (68.0) | |
>50 | 36 | 20 (40.0) | 16 (32.0) | |
Differentiation | 0.016a | |||
Well/ moderately | 56 | 22 (44.0) | 34 (68.0) | |
Poor | 44 | 28 (56.0) | 16 (32.0) | |
Clinical stage | 0.069 | |||
I-II | 43 | 26 (52.0) | 17 (34.0) | |
III-IV | 57 | 24 (48.0) | 33 (66.0) | |
Tumor size (cm) | 0.016a | |||
≤3.5 | 50 | 19 (38.0) | 31 (52.0) | |
>3.5 | 50 | 31 (52.0) | 19 (38.0) | |
Lymph node metastasis | 0.420 | |||
No | 44 | 20 (40.0) | 24 (48.0) | |
Yes | 56 | 30 (60.0) | 26 (52.0) | |
T classification | 0.838 | |||
T1-T2 | 61 | 31 (62.0) | 30 (60.0) | |
T3-T4 | 39 | 19 (38.0) | 20 (40.0) |
Data were analyzed by Chi-squared test.
P<0.05. miR, microRNA.